GLP-1 analogues have revolutionized in obesity and type 2 diabetes; However, health experts say they come with real risks and restrictions that patients should know about. In an interview with HT Lifestyle, D -R -Josson Paul Sharma, MBBS, MD (internal medicine) -a diabetologist consultant at the Sharma hospital, showed that “general side effects include nausea, bloating and other gastric problems.”
Here’s the real reason you don’t lose weight
Dr. Jasan Paul Sharma shared: “These medicines are expensive, often not covered with insurance and impossible for long -term use. Quick weight loss without proper nutrition can reduce the slim muscle, and many patients experience weighting after stopping medication.
Plan of weight loss approved by the doctor
According to Dr. Paul, persistent obesity management is achieved through practical lifestyle interventions.
1. He advised: “Focus on whole, unprocessed, fiber -rich products, while reducing the consumption of ultra -processed carbohydrates and sugary drinks.”
2. He claimed that resistance training is necessary not only to walk, but also by the exercises that build and retain the muscles. This is because walking is considered only when you can maintain a pace of 120 steps per minute.
3. D -R Sharma also recommended: “Sleep is another powerful metabolic lever; bad sleep increases greens and cortisol, contributing to fat. Set up for 7-9 hours of quality sleep.”
4. “Refer to emotional nutrition through tools such as a magazine, care or therapy,” said D -Rale.
5. First of all, remember that the sequence is more important than perfection, emphasized Dr. Paul.
Health expert completed the proposal: “When using GLP-1 drugs, when used should be combined with a comprehensive, structured lifestyle plan. They are best suited for obese patients and diabetes or those who have severe metabolic dysfunction.
Note for readers: This article is intended only for information purposes rather than to replace professional medical advice. Always seek the advice of a doctor with any medical issues.
